Lilley H, Dennett X, Byrne E
Neurology Department, St Vincent's Hospital, Fitzroy, Australia.
J R Soc Med. 1994 Jun;87(6):323-6. doi: 10.1177/014107689408700608.
Prognostic factors were analysed in 77 patients with idiopathic inflammatory myopathy identified over a 5 year period. Formal statistical tests did not differentiate useful prognostic indices and a polymyositis disability score was devised in an attempt to gain some prognostic information. Partial (47%) or full (31%) recovery were seen in most cases with no recovery of strength (9%) and death (11%) being less common outcomes. Onset before the age of 50 and duration of symptoms of less than 12 months prior to presentation were favourable prognostic features, and treatment with regimes other than steroid therapy alone a probable favourable indicator. Level of creatine kinase (CK) at presentation and histopathological separation of dermatomyositis or polymyositis failed to alter prognosis. Most patients who died did so within the initial 6 months of treatment. Four of five patients < 50 years old with either a fatal outcome or no improvement were treated with steroids alone. Large multi-centre studies are required to provide reliable data about prognostic factors in idiopathic inflammatory myopathies and the methodology used in this study can only be regarded as providing pointers towards possible prognostic factors rather than being definitive.
对在5年期间确诊的77例特发性炎性肌病患者的预后因素进行了分析。正式的统计学检验未能区分有用的预后指标,因此设计了一项多发性肌炎残疾评分,试图获取一些预后信息。大多数病例出现部分(47%)或完全(31%)恢复,力量未恢复(9%)和死亡(11%)的情况较少见。发病年龄小于50岁以及就诊前症状持续时间少于12个月是良好的预后特征,而采用非单纯类固醇治疗方案可能是一个有利指标。就诊时肌酸激酶(CK)水平以及皮肌炎或多发性肌炎的组织病理学区分未能改变预后。大多数死亡患者在治疗的最初6个月内死亡。5例年龄小于50岁且预后不良或无改善的患者中有4例仅接受了类固醇治疗。需要开展大型多中心研究以提供关于特发性炎性肌病预后因素的可靠数据,本研究中使用的方法只能被视为提供了可能的预后因素的线索,而非定论。